Chemed Corporation
CHE
$403.47
-$4.41-1.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.06% | 6.45% | 7.55% | 8.52% | 7.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.06% | 6.45% | 7.55% | 8.52% | 7.37% |
| Cost of Revenue | 8.23% | 11.06% | 11.44% | 9.62% | 7.60% |
| Gross Profit | -3.65% | -1.85% | 0.62% | 6.54% | 6.95% |
| SG&A Expenses | -1.08% | 0.18% | -0.17% | 2.10% | 6.05% |
| Depreciation & Amortization | 2.84% | 2.53% | 2.19% | 2.24% | 3.59% |
| Other Operating Expenses | -- | 96.45% | 96.73% | 97.51% | -- |
| Total Operating Expenses | 6.17% | 8.63% | 8.80% | 7.91% | 7.15% |
| Operating Income | -7.63% | -5.30% | 0.83% | 11.99% | 8.59% |
| Income Before Tax | -10.94% | -6.20% | 0.20% | 12.91% | 14.01% |
| Income Tax Expenses | -7.11% | -1.67% | 13.15% | 26.95% | 25.18% |
| Earnings from Continuing Operations | -12.17% | -7.60% | -3.51% | 8.94% | 10.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.17% | -7.60% | -3.51% | 8.94% | 10.82% |
| EBIT | -7.63% | -5.30% | 0.83% | 11.99% | 8.59% |
| EBITDA | -6.18% | -4.17% | 1.08% | 10.68% | 7.97% |
| EPS Basic | -8.29% | -4.77% | -1.52% | 10.36% | 11.17% |
| Normalized Basic EPS | -6.81% | -5.04% | 0.43% | 12.18% | 15.28% |
| EPS Diluted | -7.77% | -4.42% | -1.34% | 10.52% | 11.14% |
| Normalized Diluted EPS | -6.25% | -4.66% | 0.61% | 12.34% | 15.20% |
| Average Basic Shares Outstanding | -4.15% | -3.12% | -2.15% | -1.25% | -0.17% |
| Average Diluted Shares Outstanding | -4.71% | -3.54% | -2.35% | -1.40% | -0.08% |
| Dividend Per Share | 22.22% | 23.53% | 25.00% | 20.25% | 15.38% |
| Payout Ratio | 0.33% | 0.30% | 0.26% | 0.09% | 0.04% |